
Pimicotinib, a once-daily oral CSF-1R inhibitor, is now FDA approved for adults with TGCT for whom surgery may worsen function or cause severe morbidity.
With President Obama and congressional Republicans turning to address the looming budget crisis, a coalition of consumer groups, labor unions and major employers is pushing new approaches to control federal health spending without cutting benefits for seniors and others who rely on Medicare and Medicaid.
Read the full story:
Source: The Los Angeles Times





